A detailed history of Everence Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 88,091 shares of MRK stock, worth $9.08 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
88,091
Previous 88,091 -0.0%
Holding current value
$9.08 Million
Previous $11.4 Million 12.11%
% of portfolio
0.63%
Previous 0.79%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $2.07 Million - $2.26 Million
20,700 Added 30.72%
88,091 $9.6 Million
Q3 2023

Oct 16, 2023

SELL
$102.95 - $114.33 $1.09 Million - $1.21 Million
-10,580 Reduced 13.57%
67,391 $6.94 Million
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $985,448 - $1.26 Million
11,270 Added 16.9%
77,971 $8.65 Million
Q1 2022

Apr 11, 2022

SELL
$73.51 - $82.4 $169,808 - $190,344
-2,310 Reduced 3.35%
66,701 $5.47 Million
Q4 2021

Jan 28, 2022

BUY
$72.28 - $90.54 $1.34 Million - $1.68 Million
18,530 Added 36.71%
69,011 $5.29 Million
Q3 2021

Oct 21, 2021

SELL
$71.68 - $78.83 $654,438 - $719,717
-9,130 Reduced 15.32%
50,481 $3.79 Million
Q4 2020

Feb 01, 2021

SELL
$71.77 - $79.65 $825,355 - $915,975
-11,500 Reduced 16.17%
59,611 $4.88 Million
Q2 2020

Jul 09, 2020

BUY
$70.42 - $80.13 $465,476 - $529,659
6,610 Added 10.25%
71,111 $5.74 Million
Q4 2019

Jan 28, 2020

SELL
$77.58 - $87.54 $125,679 - $141,814
-1,620 Reduced 2.45%
64,501 $5.87 Million
Q1 2019

May 06, 2019

BUY
$69.58 - $79.36 $515,935 - $588,454
7,415 Added 12.63%
66,121 $5.5 Million
Q1 2018

Apr 30, 2018

SELL
$50.96 - $59.23 $319,519 - $371,372
-6,270 Reduced 9.65%
58,706 $3.2 Million
Q4 2017

Feb 02, 2018

BUY
$51.62 - $61.64 $38,766 - $46,291
751 Added 1.17%
64,976 $3.66 Million
Q3 2017

Oct 31, 2017

BUY
$58.67 - $63.13 $3.77 Million - $4.05 Million
64,225
64,225 $4.11 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.